The cytoprotective drug rebamipide in therapy for inflammatory and erosive-ulcerative lesions of the gastrointestinal tract
- Authors: Yakovenko EP1, Agafonova NA1, Ivanov AN1, Yakovenko AV1, Aldiyarova MA1, Volosheinikova TV1, Grigoryeva Y.V1, Soluyanova IP1
-
Affiliations:
- Issue: Vol 88, No 4 (2016)
- Pages: 88-92
- Section: Editorial
- Submitted: 10.04.2020
- Published: 15.04.2016
- URL: https://ter-arkhiv.ru/0040-3660/article/view/31991
- ID: 31991
Cite item
Full Text
Abstract
About the authors
E P Yakovenko
N A Agafonova
A N Ivanov
A V Yakovenko
M A Aldiyarova
T V Volosheinikova
Yu V Grigoryeva
I P Soluyanova
References
- Rose S, ed. Gastrointestinal and Hepatobiliary pathophysiology. Madison, Connecticut: Fence Greek Publishing, LLC; 1998.
- Whittle BJR. Protective mechanisms of the gastric mucosa. In Gustavsson S, Kumar D, Graham DY, eds. The stomach. Edinburgh, London, Madrid: Churchill Livingstone; 1992:81-101.
- Sol AH. Peptic ulcer and its complications. In Sleisenger M, Fordtrans JS, eds. Gastrointestinal and Liver Disease. Philadelphia-London-Toronto-Monreal-Sydney-Tokyo; 2003.
- Григорьев П.Я., Яковенко А.В. Клиническая гастроэнтерология. 3-е издание. М.: МИА; 2004.
- Feldman M, Scharschmidt BF, Sleisenger MH, Fordtran JS, eds. Sleisenger and Fordtran‘s Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 6th ed. W.B. Saunders Company; 1998.
- Яковенко Э.П., Яковенко А.В., Илларионова Ю.В., Иванов А.Н., Агафонова Н.А., Прянишникова А.С., Солуянова И.П. Ингибиторы протонной помпы в профилактике и терапии стрессовых язв. Лечащий врач. 2010;(2):52-55.
- Яковенко Э.П., Яковенко А.В., Илларионова Ю.В., Агафонова Н.А., Лаврентьева С.А, Иванов А.Н., Прянишникова А.С., Краснолобова Л.П. Пантопразол в терапии кислотозависимых заболеваний. Фарматека. 2012;2:45-50.
- Кононов А.В. Гетерогенность воспалительного ответа в популяции при Helicobacter pylori-инфекции. Педиатрия. 2002;2(прил.):124-130.
- Prichard P, Walt R, Chapman R. Drugs for the GUT. A practical guide to gastrointestinal and liver therapy. London, Philadelphia, Toronto, Sydney: WB Saunders company limited; 1998.
- Яковенко А.В., Григорьев П.Я., Яковенко Э.П., Агафонова Н.А., Прянишникова А.С., Иванов А.Н., Алдиярова М.А., Солуянова И.П., Анашкин В.А., Оприщенко И.В. Цитопротекторы в терапии заболеваний желудка. Оптимальный подход к выбору препарата. Клиническая и экспериментальная диагностика. 2006;2:56-60.
- Arakawa T, Higuchi K, Fujiwara Y et al. 15th Anniversary of Rebamipide: Looking Ahead to the New Mechanisms and New Applications. Dig Dis Sci. 2005;50(1):S3-S11. doi: 10.1007/s10620-005-2800-9.
- Nebiki H, Higuchi K, Arakawa T et al. Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer. Dig Dis Sci. 1998;(43):203-206.
- Haruma K, Ito М, Kido S et al. Long-term rebamipide therapy improves Helicobacter pylori-associated chronic gastritis. Dig Dis Sci. 2002;47:862-867. doi: 10.1023/a:1014716822702.
- Higuchi K, Arakawa T, Nebiki H et al. Rebamipide prevents recurrence of gastric ulcers without affecting Helicobacter pylori status. Dig Dis Sci. 1998;43:99S-106S.
- Kim H, Seo JY, Kim KH. Inhibition of lipid peroxidation, NFkappaB activation and IL-8 production bу rebamipide in Helicobacter pylori-stimulated gastric epithelial cells. Dig Dis Sci. 2000;45:621-628. doi: 10.1023/a:1005474013988.
- Takaishi O, Arakawa T, Yamasaki K, Fujiwara Y, Uchida T, Tominaga K, Watanabe T, Higuchi K, Fukuda T, Kobayashi K and Kuroki T. Protective effect of rebamipide against ammonia-induced gastric mucosal lesions. Dig Dis Sci. 1998;43:78s-82s.
- Мatysiak-Budnik T, Thomas-Collignon A, Megraud F, Heyman M. Alterations of epithelial permeability by HeIicobacter and IL-Iβ in vitro: protective effect of rebamipide. Dig Dis Sсi. 2001;46:1558-1566. doi: 10.1023/a:1010664626431.
- Nebiki H, Atakawa T, Higuchi K, Kobayashi K. Quality of ulcer healing influences the relapse of gastic ulcers in humans. J Gastroentrol Hepatol. 1997;12:109-114. doi: 10.1111/j.1440-1746.1997.tb00393.x.
- Takayama M. Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers. World J Gastroenterol. 2013;19(34):5706-5712. doi: 10.3748/wjg.v19.i34.5706.
- Ishihara K, Komuro Y, Nishiyama N et al. Effect of rebamipide on mucus secretion by endogenous prostaglandin-independet mechanism. Drag Res. 1992;42:1462-1466.
- Watanabe S, Wang X-E, Hirose M. et al. Effects of rebamipide on bile acid induced inhibition of gastric epithelial repair in a rabbit cell culture model. Aliment Pharmacol Ther. 1996;10(6):927-932. doi: 10.1046/j.1365-2036.1996.105276000.x.
- Tarnawski A, Arakawa T, Kobayashi K. Rebamipide treatment activates EGF and its receptor expression in normal and ulcerated gastric mucosa. The molecular mechanism of its ulcer healing action. J Gastroenterol Hepatol. 1997;12(suppl):A221.
- Naito Y, Yoshikawa T, Iinuma S et al. Local gastric and serum concentrations of rebamipide following oral administration to patients with chronic gastritis. Arzneimittelforschung. 1996;46:698-700.
- Tarnawski A, Pai R, Chiou S, Chai J, Chu E. Rebamipide inhibits gastric cancer growth by targeting survivin and Aurora-B. Biochem Biophys Res Commun. 2005;334(1):207-212. doi: 10.1016/j.bbrc.2005.05.204.
- Hawkey C. Non-steroidal anti-inflammatory drugs: overall risks and management. Complementary roles for COX-2 inhibitors and proton pump inhibitors. Gut. 2003;52(4):600-608. doi: 10.1136/gut.52.4.600.
- Endo H, Sakai E, Higurashi T et al. Differences in the severity of small bowel mucosal injury based on the type of aspirin as evaluated by capsule endoscopy. Dig Liver Dis. 2012;44(10):833-838. doi: 10.1016/j.dld.2012.05.016.
- Takeuchi K, Tanaka A, Kato S, Amagase K, Satoh H. Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage. Clin Chim Acta. 2010;411(7-8):459-466. doi: 10.1016/j.cca.2009.12.026.
- Mizoguchi H, Ogawa Y, Kanatsu K, Tanaka A, Kato S, Takeuchi K. Protective effect of rebamipide on indomethacin-induced intestinal damage in rats. J Gastroenterol Hepatol. 2001;16(10):1112-1119. doi: 10.1046/j.1440-1746.2001.02592.x.
- Kurokawa S, Katsuki S, Fujita T et al. A randomized, double-blinded, placebo-controlled, multicenter trial, healing effect of rebamipide in patients with low-dose aspirin and/or non-steroidal anti-inflammatory drug induced small bowel injury. J Gastroenterol. 2013;49(2):239-244. doi: 10.1007/s00535-013-0805-2.